在过去九年里，随着患者需求和医疗市场的变化，扎克·雷塔诺多次推动Ro进行转型，从早期的直接面向患者服务发展为GLP-1（胰高血糖素样肽-1）护理领域的领先平台。
Over nine years, Zach Reitano has repeatedly evolved Ro as patient needs and the healthcare market have changed, from its early direct-to-patient services to a leading platform for GLP-1 care.
在《商业内幕》的《长期主义》栏目中，雷塔诺探讨了这些转型背后的商业决策，以及公司如何为消费者健康的下一个时代做好定位。
During Business Insider's The Long Play, Reitano discussed the business decisions behind those shifts and how the company is positioning itself for the next era of consumer health.
作为与《商业内幕》法律记者梅利亚·罗宾逊对话的一部分，他还分享了自己作为创始人、在快速且持续不断的变革时代领航所获得的经验教训。
As part of his conversation with Business Insider legal correspondent Melia Robinson, he also shared what he's learned as a founder leading in an era of quick and unrelenting change.